These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 20544351

  • 21. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N, Badsberg JH, Lönnqvist B, Ringdén O, Volin L, Rajantie J, Nikoskelainen J, Keiding N.
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [Abstract] [Full Text] [Related]

  • 22. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R, Peters C, Minkov M, Emminger-Schmidmeier W, Mann G, Höcker P, Hawliczek R, Rosenmayr A, Fink FM, Niederwieser D, Gadner H.
    Klin Padiatr; 1997 Jun; 209(4):201-8. PubMed ID: 9293451
    [Abstract] [Full Text] [Related]

  • 23. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Jun; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 24. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome.
    Zaja F, Russo D, Silvestri F, Fanin R, Damiani D, Infanti L, Salmaso F, Mariuzzi L, Di Loreto C, Baccarani M.
    Haematologica; 1997 Jun; 82(2):171-7. PubMed ID: 9175321
    [Abstract] [Full Text] [Related]

  • 25. Outcome of allogeneic peripheral blood stem cell transplantation using matched sibling donors in patients with high-risk hematological diseases.
    Sohn SK, Kim DH, Kim JG, Sung WJ, Baek JH, Lee NY, Won DI, Suh JS, Lee KS, Lee KB.
    Eur J Haematol; 2004 Jun; 72(6):430-6. PubMed ID: 15128422
    [Abstract] [Full Text] [Related]

  • 26. [Allogeneic transplantation in malignant lymphoma].
    Stötzer OJ, Schleuning M, Ledderose G, Hiddemann W, Kolb HJ.
    Dtsch Med Wochenschr; 2001 Sep 28; 126(39):1062-9. PubMed ID: 11602913
    [Abstract] [Full Text] [Related]

  • 27. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
    Topolsky D, Crilley P, Styler MJ, Bulova S, Brodsky I, Marks DI.
    Bone Marrow Transplant; 1996 Apr 28; 17(4):549-54. PubMed ID: 8722353
    [Abstract] [Full Text] [Related]

  • 28. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S, Nakaseko C, Nishimura M, Maruta A, Cho R, Ohwada C, Sakamaki H, Sao H, Mori S, Okamoto S, Miyamura K, Kato S, Kawase T, Morishima Y, Kodera Y, Japan Marrow Donor Program.
    Br J Haematol; 2007 Apr 28; 137(2):142-51. PubMed ID: 17391494
    [Abstract] [Full Text] [Related]

  • 29. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan 28; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 30. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.
    Phillips GL, Barnett MJ, Brain MC, Chan KW, Huebsch LB, Klingemann HG, Meharchand J, Reece DE, Rybka WB, Shepherd JD.
    Bone Marrow Transplant; 1991 Dec 28; 8(6):477-87. PubMed ID: 1790428
    [Abstract] [Full Text] [Related]

  • 31. Reduced-intensity conditioning regimen using low-dose total body irradiation before allogeneic transplant for hematologic malignancies: Experience from the European Group for Blood and Marrow Transplantation.
    Belkacémi Y, Labopin M, Hennequin C, Hoffstetter S, Mungai R, Wygoda M, Lundell M, Finke J, Aktinson C, Lorchel F, Durdux C, Basara N.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):544-51. PubMed ID: 17141976
    [Abstract] [Full Text] [Related]

  • 32. Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant.
    Shaw BE, Mufti GJ, Mackinnon S, Cavenagh JD, Pearce RM, Towlson KE, Apperley JF, Chakraverty R, Craddock CF, Kazmi MA, Littlewood TJ, Milligan DW, Pagliuca A, Thomson KJ, Marks DI, Russell NH.
    Bone Marrow Transplant; 2008 Dec 01; 42(12):783-9. PubMed ID: 18724393
    [Abstract] [Full Text] [Related]

  • 33. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
    Ozcan M, Ustün C, Akçağlayan E, Akan H, Arslan O, Ilhan O, Beksaç M, Gürman G, Demirer T, Arat M, Celebi H, Konuk N, Uysal A, Koç H.
    Bone Marrow Transplant; 2001 Mar 01; 27(5):499-505. PubMed ID: 11313683
    [Abstract] [Full Text] [Related]

  • 34. [Allogeneic peripheral blood stem cell transplantation in the treatment of hematologic malignancies].
    Wang F, Huang X, Ren H, Zhang Y, Xu L, Chen Y, Liu K, Guo N, Lu D.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug 01; 23(8):403-6. PubMed ID: 12411042
    [Abstract] [Full Text] [Related]

  • 35. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ.
    Br J Haematol; 2002 Feb 01; 116(2):483-90. PubMed ID: 11841456
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
    Saito T, Kanda Y, Kami M, Kato K, Shoji N, Kanai S, Ohnishi T, Kawano Y, Nakai K, Ogasawara T, Matsubara H, Makimoto A, Tanosaki R, Tobinai K, Wakasugi H, Takaue Y, Mineishi S.
    Clin Cancer Res; 2002 Apr 01; 8(4):1014-20. PubMed ID: 11948108
    [Abstract] [Full Text] [Related]

  • 38. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M, Theuser C, Soucek S, Hölig K, Klingebiel T, Blau W, Fauser A, Runde V, Schwinger W, Rutt C, Ehninger G.
    Haematologica; 2000 Aug 01; 85(8):839-47. PubMed ID: 10942931
    [Abstract] [Full Text] [Related]

  • 39. Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies.
    Hoffmeister PA, Storer BE, Macris PC, Carpenter PA, Baker KS.
    Biol Blood Marrow Transplant; 2013 Jul 01; 19(7):1081-6. PubMed ID: 23623893
    [Abstract] [Full Text] [Related]

  • 40. High readmission rates are associated with a significant economic burden and poor outcome in patients with grade III/IV acute GvHD.
    Dignan FL, Potter MN, Ethell ME, Taylor M, Lewis L, Brennan J, McNamara L, Evans SO, Riley U, Davies FE, Dearden CE, Morgan GJ, Shaw BE.
    Clin Transplant; 2013 Jul 01; 27(1):E56-63. PubMed ID: 23278853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.